Soluble Glucan Is Internalized and Trafficked to the Golgi Apparatus in Macrophages via a Clathrin-Mediated, Lipid Raft-Regulated Mechanism

Glucans are natural product carbohydrates that stimulate immunity. Glucans are internalized by the pattern recognition receptor, Dectin-1. Glucans were thought to be trafficked to phagolysosomes, but this is unproven. We examined the internalization and trafficking of soluble glucans in macrophages. Incubation of macrophages with glucan resulted in internalization of Dectin-1 and glucan. Inhibition of clathrin blocked internalization of the Dectin-1/glucan complex. Lipid raft depletion resulted in decreased Dectin levels and glucan uptake. Once internalized, glucans colocalized with early endosomes at 0 to 15 min, with the Golgi apparatus at 15 min to 24 h, and with Dectin-1 immediately (0 h) and again later (15 min-24 h). Glucans did not colocalize with lysosomes at any time interval examined. We conclude that the internalization of Dectin-1/glucan complexes in macrophages is mediated by clathrin and negatively regulated by lipid rafts and/or caveolin-1. Upon internalization, soluble glucans are trafficked via endosomes to the Golgi apparatus, not lysosomes.

[1]  David L. Williams,et al.  Internalization of Dectin-1 terminates induction of inflammatory responses , 2009, European journal of immunology.

[2]  P. Taylor,et al.  The Induction of Inflammation by Dectin-1 In Vivo Is Dependent on Myeloid Cell Programming and the Progression of Phagocytosis1 , 2008, The Journal of Immunology.

[3]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[4]  S. Gordon,et al.  Prolonged Reduction of Leukocyte Membrane-Associated Dectin-1 Levels following β-Glucan Administration , 2006, Journal of Pharmacology and Experimental Therapeutics.

[5]  R. Busund,et al.  Cardioprotective effect of pretreatment with β-glucan in coronary artery bypass grafting , 2006, Scandinavian cardiovascular journal : SCJ.

[6]  Andrew H. Limper,et al.  Macrophage Internalization of Fungal β-Glucans Is Not Necessary for Initiation of Related Inflammatory Responses , 2005, Infection and Immunity.

[7]  D. Underhill,et al.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. , 2005, Blood.

[8]  J. Kalbfleisch,et al.  Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge , 2005, Journal of Pharmacology and Experimental Therapeutics.

[9]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[10]  Jeffrey L. Wrana,et al.  Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling , 2005, Nature Reviews Molecular Cell Biology.

[11]  S. Gordon,et al.  Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. , 2004, Blood.

[12]  T. Hartung,et al.  Lipoteichoic Acid and Toll-like Receptor 2 Internalization and Targeting to the Golgi Are Lipid Raft-dependent* , 2004, Journal of Biological Chemistry.

[13]  David L. Williams,et al.  Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats. , 2004, International immunopharmacology.

[14]  Jun Yan,et al.  Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models1 , 2004, The Journal of Immunology.

[15]  S. Ramamoorthy,et al.  Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters , 2004, Journal of Biological Chemistry.

[16]  David L. Williams,et al.  Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection. , 2004, Cardiovascular research.

[17]  M. Lisanti,et al.  The Caveolin genes: from cell biology to medicine , 2004, Annals of medicine.

[18]  J. Kalbfleisch,et al.  Serum Glucan Levels Are Not Specific for Presence of Fungal Infections in Intensive Care Unit Patients , 2003, Clinical Diagnostic Laboratory Immunology.

[19]  S. Gordon,et al.  Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.

[20]  Shizuo Akira,et al.  Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.

[21]  I. Nabi,et al.  Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum , 2003, Journal of Cell Science.

[22]  Douglas T. Golenbock,et al.  Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction* 210 , 2002, The Journal of Biological Chemistry.

[23]  S. Gordon,et al.  The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages1 , 2002, The Journal of Immunology.

[24]  Siamon Gordon,et al.  Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.

[25]  David L. Williams,et al.  Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor‐1 dependent mechanism , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[26]  S. Gordon,et al.  Immune recognition: A new receptor for β-glucans , 2001, Nature.

[27]  L. Norkin.  Caveolae in the uptake and targeting of infectious agents and secreted toxins. , 2001, Advanced drug delivery reviews.

[28]  R. Ritter,et al.  Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning* , 2000, The Journal of Biological Chemistry.

[29]  S. Wright,et al.  Transport of Bacterial Lipopolysaccharide to the Golgi Apparatus , 1999, The Journal of experimental medicine.

[30]  Yoshiko Nakamura,et al.  [The Clinical Significance of Plasma] , 1998, Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology.

[31]  David L. Williams.  Overview of (1→3)-β-D-glucan immunobiology , 1997, Mediators of inflammation.

[32]  T. Tani,et al.  Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[33]  Edward J. Walsh.  Chemistry and Biology , 1996 .

[34]  W. Browder,et al.  Glucan-Based Macrophage Stimulators , 1996, Clinical Immunotherapeutics.

[35]  E. Jones,et al.  Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. , 1995, Journal of chromatography. B, Biomedical applications.

[36]  E. Jones,et al.  NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Carbohydrate research.

[37]  E. Jones,et al.  A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1991, Carbohydrate research.

[38]  N. Tatsumi,et al.  Evaluation of a new laboratory test measuring plasma (1-->3)-beta-D-glucan in the diagnosis of Candida deep mycosis: comparison with a serologic test. , 1999, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[39]  David L. Williams,et al.  IDENTIFICATION OF PHOSPHATE SUBSTITUTION SITES BY NMR SPECTROSCOPY IN A WATER-SOLUBLE PHOSPHORYLATED (13)-BETA -D-GLUCAN , 1998 .

[40]  D. Williams,et al.  Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Microbios.